A systematic approach to uncover the basic mechanisms of checkpoint inhibitor immune related adverse events

Immunology and Microbiology

1. Allotype 16%
2. Autoimmune Disease 50%
3. CTLA-4 16%
4. Hematopoietic Stem Cell 16%
5. Immune Response 16%
6. Immune System 16%
7. Inflammation Response 16%
8. Mouse 16%
9. Mouse Model 33%
10. T Cell 100%
11. T Cell Receptor 66%
12. Target Organ 16%
13. Target Tissue 16%
14. Tumor Antigen 16%
15. Tumor-Infiltrating Lymphocytes 16%